NiketaCShahMD
Pediatric Hematology & Oncology • New Brunswick, NJChief, Pediatric Stem Cell Transplant and Cellular Therapy Physician Rutgers Cancer Institute of New Jersey
Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
195 Little Albany St
Ste 2900
New Brunswick, NJ 08901Phone+1 732-235-2465Fax+1 732-235-8234
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Pediatric Stem Cell Transplant, 2009 - 2010
Rutgers Health/Newark Beth Israel Medical CenterResidency, Pediatrics, 2006 - 2009
Hospital for Sick ChildrenPediatric Hematology Oncology Fellowship, 2003 - 2006- Gujarat Cancer and Research InstitutePediatric Hematology Oncology, 1997 - 2003
- Sheth KM School of Post Graduate Medicine and ResearchMD, Pediatric Residency , 1994 - 1997
N.H.L Municipal Medical CollegeClass of 1994
Certifications & Licensure
NJ State Medical License 2023 - 2025
CT State Medical License 2016 - 2024
AZ State Medical License 2010 - 2017
WI State Medical License 2008 - 2009- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors Start of enrollment: 2019 Apr 03
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 5 citationsIncidence and risk factors of pain crisis after hematopoietic cell transplantation for sickle cell disease.Lakshmanan Krishnamurti, Jingchen Liang, Zili He, Yanhong Deng, Vineetha R Nallagatla
Blood Advances. 2024-04-23 - Mixed donor chimerism following stem cell transplantation for sickle cell disease.Niketa C Shah, Hemalatha G Rangarajan, Alexander Ngwube, Shalini Shenoy
Current Opinion in Hematology. 2023-11-01 - 2 citationsCan defibrotide prophylaxis prevent sinusoidal obstruction syndrome following haematopoietic stem-cell transplantation?Niketa C Shah, Shalini Shenoy
The Lancet. Haematology. 2023-05-01
Abstracts/Posters
- Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated Following Allogeneic Transplantation in Patients with Sickle Cell DiseaseNiketa C. Shah, MD , Sweta Bhoopatiraju , Allistair Abraham, MD , Eric Jon Anderson, MD , Martin Andreansky, MD , Monica Bhatia, MD , Sonali Chaudhury, MD , Geoff D.E...., American Society of Hematology, Virtual, 12/5/2020
- Allogeneic CD34-Selected HSCT Following CAR T-Cells Is Associated with Low TRM and Favorable OS in Pediatric/Young Adult Patients with Relapsed/Refractory B-ALLNiketa C. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Abatacept Is Effective for Gvhd Prophylaxis after Unrelated Donor Stem Cell Transplantation (URD SCT) for Severe Sickle Cell Disease (SCD)Niketa C. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Professional Memberships
- Member
- American Society for Transplantation and Cellular TherapyMember
Other Languages
- Hindi, Gujarati
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
